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Abstract To study the structure-activity relationships of brain 
injury-derived neurotrophic peptide (BINP), 12 analogs were 
synthesized by replacing each amino acid residue with Gly. BINP 
showed CD spectra typical of an c~-helical conformation in TFE 
solution which mimics the membrane environment. In the co- 
helical conformation, BINP showed an amphiphilic profile. 
Neurotrophic activities of BINP and its analogs were estimated 
from the effects on supporting septal cholinergic neurons and on 
rescuing hippocampal neurons from injury caused by glutamate. 
Both assays showed that the residues on the hydrophobic side of 
the amphiphilic helix were essential for the neurotrophic activity. 
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1. Introduction 
Neuronal  activities and survival are supported by several 
kinds of proteins. Among them, neurotrophic factors have 
been reported to play important  roles in various developmen- 
tal stages. Even after injury to or disease of a mature central 
nervous system, parts of neurons are rescued and are able to 
survive. Treatment with neurotoxins or mechanical injury to 
the brain increases the synthesis of several kinds of factors in 
the brain [1,2]. These factors, which are up-regulated after 
injury, are thought to act on neurons to support  their survi- 
val. The activities of these factors were mainly investigated in 
vitro and also sometimes in vivo, and it was shown that they 
supported neuronal  survival directly or indirectly via glial 
cells. 
In the course of investigating neurotrophic factors that ap- 
peared after injury to rat brains and rescued neurons from 
injury or excitotoxin, we purified a protein from gelforms 
implanted in cavities of neonatal  rat brains [3]. Dur ing ana- 
lysis of amino acid sequences of peptide fragments, we found 
that a 13-mer peptide named BINP, which was synthesized 
based on an amino acid sequence of one of the fragmentary 
peptides, has a neurotrophic activity. B INP supported neuro- 
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nal survival of septal cholinergic neurons and mesencephalic 
dopaminergic neurons in primary cultures from neonatal  rats 
[3]. Furthermore,  BINP rescued neurons from injury caused 
by glutamate ven when it was applied at 4.5 h after treatment 
with glutamate in a pr imary culture of h ippocampal neurons. 
Since these effects were reproducible in cultures with or with- 
out astroglial feeder layer, presumably B INP acted on the 
neurons. Because BINP is a small 13-mer peptide and may 
be of clinical interest, it is worth investigating which amino 
acid residue is important  in this activity. 
In the present study, we synthesized 12 analogs of BINP in 
which each amino acid residue except Gly s was replaced with 
a Gly residue in order to examine the structure-activity rela- 
t ionships of the peptide (Table 1). The effects of the substitu- 
tions were compared using many criteria, such as theoretical 
hydrophobicity, retention time on reverse phase HPLC, CD 
spectra, neurotrophic activity support ing the survival of cul- 
tured septal cholinergic neurons, and rescuing neurons from 
injury caused by glutamate treatment of cultured hippocampal 
neurons. 
2. Materials and methods 
2.1. Peptide ~2vnthesis 
Fmoc amino acids and other reagents used on the synthesizer were 
obtained from Applied Biosystems Japan (Chiba, Japan). Fmoc-NH- 
SAL-resin was obtained from Watanabe Chemical Industries Ltd. 
(Hiroshima, Japan). Other reagents of peptide synthesis grade were 
obtained from the Peptide Institute (Osaka, Japan) or Kokusan 
Chemical Works Ltd. (Tokyo, Japan). 
Solid phase peptide synthesis was conducted on an Applied Biosys- 
terns 431A peptide synthesizer. Amino acid analyses were performed 
on a Beckman System Gold amino acid analyzer after hydrolysis in 6 
M hydrochloric acid at ll0°C for 24 h and derivatization by 4-di- 
methylaminoazobenzene-4'-sulfonyl chloride. FAB-MS were meas- 
ured on a JEOL HX-100 mass spectrometer. Analytical HPLC was 
carried out on a Shimadzu LC-6A system with an ODS column 
(4.6 × 250 mm). Preparative HPLC was performed with a Shimadzu 
LC-8A system with an ODS column (20×250 mm). 
All the analogs were synthesized by solid phase methodology of 
Fmoc chemistry. After TFA cleavage, crude peptides were extracted 
with 2 M AcOH and lyophilized. The crude products were purified by 
successive chromatography with Sephadex G-25F and preparative 
HPLC with an ODS column. Structures and purity of synthetic pep- 
tides were confirmed by analytical HPLC, amino acid analysis, and 
FAB-MS measurement. 
Abbrev&tions." BINP, brain injury-derived neurotrophic peptide; Boc, 
t-butoxycarbonyl; CHAT, choline acetyltransferase; DMEM, Dulbec- 
co's modified Eagle's medium; FAB-MS, fast atom bombardment 
mass spectrometry; HPLC, high performance liquid chromatography; 
Fmoc, 9-fluorenylmethoxycarbonyl; NGF, nerve growth factor; ODS, 
octadecylsilane; TFA, trifluoroacetic acid; TFE, trifluoroethanol; 
Analogs are designated by a letter and number indicating the identity 
and position of the replaced amino acid, followed by a letter indicating 
the identity of the replacement; for example, E1G indicates an analog 
in which Glu ~ is replaced with Gly 
2.2. CD measurements 
CD spectra were recorded on a JASCO J-600 spectropolarimeter in 
H20 solution (0.01 M sodium phosphate, pH 7.0) and in TFE solu- 
tion at 20°C using a cell of 1 mm path length. The sample concentra- 
tion was 0.05 mM and corrected by quantitative amino acid analysis. 
The spectra re expressed as mean residual ellipticity [0]. 
2.3. Assay of neurotrophic activities 
Primary cell cultures were prepared following the method of Hata- 
naka et al. [4,5]. Briefly, the septal area was dissected out from Wistar 
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Fig. 1. Changes in the theoretical hydrophobicity and retention 
times on reversed-phase HPLC of BINP and its analogs. The solid 
line indicates the position of BINP as a standard. Analytical HPLC 
was carried out on a Shimadzu LC-6A system with a Shim-pack 
CLC-ODS column (4.6 × 250 mm) by applying a linear gradient of 
5-65% CH3CN in 0.1% TFA for 30 min at a flow rate of 1 ml/min 
with monitoring of the absorbance at 230 nm. 
rat neonates (9-10 days of age). Cells were dissociated with papain 
and plated on polyethyleneimine-coated plastic dishes at a density of 
about 3 × 105 cells/cm 2. Cultures were maintained for 6 days with a 
DF medium (1:1 mixture of Dulbecco's modified Eagle's medium 
(DMEM) and F-12 medium) supplemented with 5% precolostrum 
newborn calf serum, 5% heat-inactivated horse serum and 1% rat 
serum. BINP or NGF was added at the indicated concentration on 
the next day of plating. Determination of ChAT (choline acetyltrans- 
ferase) activity in the extract of cultured cells was done according to 
the method of Fonnum [6]. 
Hippocampal neurons were isolated with papain from Wistar rat 
embryos of gestational day 18, plated on polyethyleneimine-coated 
glass coverslips at a density of 1.5-2.5× 105 cells/cm 2 (dish diameter 
15 mm), and maintained for 7 days in DMEM supplemented with 5% 
precolostrum newborn calf serum and 5% heat-inactivated horse se- 
rum [3,7]. On the day of examination, after arbitrary view fields were 
photographed with a 10× phase-contrast optic, the culture medium 
was exchanged sequentially with (1) serum-free DMEM (10 min), (2) 
serum-free DMEM with or without 1.2 mM CaCl2 and 1 mM gluta- 
mate (30 min), (3) serum-free DMEM (10 min) and (4) serum-free 
DMEM with or without peptide. All treatments were done at 37°C. 
24 h later, the identical fields were photographed (to facilitate identi- 
fication, the coverslips had grating printed on the back). Cells posses- 
sing phase-bright somata and neurites (>soma diameter, without 
beading) were counted for pairs of photographs and the rates of 
remaining cells were calculated [3,7]. 
3. Results  
Most amino acids were assembled on the resin using stand- 
ard Fmoc chemistry. However, to avoid spontaneous pyro- 
glutamine formation of the N-terminal Glu residue during 
treatment with piperidine for the removal of the Fmoc group, 
an amino group of Glu 1 was protected with the Boc group. 
After that procedure, the Boc was removed by TFA treatment 
employed for the cleavage of peptide from resin support. The 
physicochemical properties of BINP and its analogs were eval- 
uated in terms of the retention times on reversed-phase 
HPLC, which is more or less related to molecular hydropho- 
bicity. As shown in Fig. 1, this property correlated well with 
theoretical hydrophobicity [8], showing that there were no 
anomalies in the molecular hydrophobicity. 
Fig. 2 shows the CD spectra of BINP and its analogs in 
H20 and in TFE solution. In H20 solution, CD spectra of all 
the analogs as well as BINP showed a simple profile with large 
negative Cotton effects of approximately 195 nm, which is 
typical of a random conformation. In TFE solution, which 
mimics the membrane nvironment, all peptides howed CD 
spectra with a double minimum of approximately 205 nm and 
222 nm, typical of a helical conformation. Fig. 3 shows the 
helical contents of the peptides calculated from mean residual 
ellipticity at 222 nm [9]. Since Gly residue is a 'helix breaker' 
[10], helical conformation is destabilized by this substitution, 
especially at the central part of the molecule. It is interesting 
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Fig. 2. CD spectra of BINP and its analogs in TFE solution (upper) and in H20 (0.01 M sodium phosphate, pH 7.0) solution (lower) at 20°C. 
The spectra are expressed as mean residual ellipticity [0]. 
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Fig. 3. Helix contents of BINP and its analogs calculated from CD 
spectra in TFE solution. The broken line indicates the helix content 
of BINP as a standard. 
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that the removal of a side chain of Glu 1 residue resulted in 
stabilization of helical conformation. 
Neurotrophic activities of BINP and its analogs were meas- 
ured using two different bioassays. The effects on supporting 
septal cholinergic neurons are summarized in Fig. 4. The ana- 
logs L5G, A6G, A9G, I10G, and A13G showed almost no 
activity at the concentration of 50 ng/ml. At higher concen- 
tration (10 ktg/ml), the analogs E IG,  A2G, L3G, E4G and 
R7G showed higher activities of 310, 226, 305, 457 and 
469% of control (mean of 4-5 samples), respectively. These 
values were quite significant (P<0.01)  by Student's t-test, 
indicating that these analogs retained an intrinsic activity. 
On the other hand, the analogs L5G, A6G, A9G, I10G, 
and A13G showed no significant increase of activity even at 
this high concentration, suggesting that they do not interact 
with BINP receptor. 
In another assay for rescuing neurons from injury caused 
by glutamate, the analogs A2G, L5G, A6G, A9G and I10G 
showed very low activity (Fig. 5). Although the results of the 
two assays were not completely in parallel as shown in the 
case of A2G and A13G, four residues at the central part, 
Leu 5, Ala 6, Ala 9 and Ile 1°, were commonly essential for 
both activities. 
4. Discussion 
In many biologically active peptides, amino acid residues 
critical for the activity are the characteristic ones such as basic 
Arg or Lys, acidic Asp or Glu, or aromatic Tyr or Phe. It is 
interesting that Glu 1, Arg 7, Phe 1], and Gin 12 in BINP are not 
important for neurotrophic activity and all the essential resi- 
dues are simple hydrophobic aliphatic amino acids. This may 
Table 1 
Amino acid sequences of BINP and its analogs ~
0 
Fig. 4. Activity of BINP analogs on survival of septal cholinergic 
neurons in cultures. Cells from septal area of PI0 rat brain were 
cultured as described in Section 2. On the next day of plating cells 
on culture dishes, each peptide or BINP was added in culture me- 
dium to a final concentration of 50 ng/ml or 5 ng/ml, respectively. 
Cells were cultured for 6 days and homogenized with 10 mM Tris- 
HC1, pH 7.5 containing 0.1% Triton X-100. ChAT activities in cell 
extracts were measured. ChAT activities of cells treated with peptide 
were compared with those of control culture (no addition). Each 
value is the mean of 4-5 samples. The ChAT activity of cells treated 
with NGF (100 ng/ml) was 473% of control (mean of 4 samples). 
*P < 0.05, **P < 0.001 by Student's t-test. 
suggest that the hydrophobic interaction is critical for the 
binding of BINP to its target molecules. 
Secondary structure prediction using the Chou and Fasman 
method [11] suggests that BINP tends to take on a helical 
conformation. This prediction was supported by CD spectrum 
analysis (Figs. 2 and 3). Interestingly, hydrophobic residues 
are clustered on one side of this helical conformation, and the 
hydrophilic ones on the other side (Fig. 6). It is also note- 
worthy that four Ala residues align almost straightforward in
the hydrophobic side. According to the method of Eisenberg 
et al. [12], BINP has an average hydrophobicity value of 0.21 
and a hydrophobic moment of 0.33, which are typical of the 
amphiphilic helix of a surface-seeking peptide. 
Although the Gly substitution affected the conformation of 
the analogs (Fig. 3), the decrease of activity cannot simply be 
explained by the conformational changes. For example, R7G, 
which is one of the analogs with lowest helicity, was potent in 
both assays. Interestingly, all the residues essential for the 
activity are located on the hydrophobic side of the helix. It 
Amino acid sequence Peptide 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-lle-Phe-Gln-Ala-NH2 
Gly-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Gly-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH~ 
Glu-Ala-Gly-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Gly-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Gly-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Gly-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Gly-Gly-Ala-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Gly-Ile-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Gly-Phe-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Gly-Gln-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gly-Ala-NH2 
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Gly-NH2 
BINP 
E1G 
A2G 
L3G 
E4G 
L5G 
A6G 
R7G 
A9G 
I10G 
F I lG 
Q12G 
AI3G 
~The substituted Gly residue is shown in bold. 
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Fig. 5. Activity of BINP analogs on rescuing hippocampal neurons 
from injury caused by glutamate. Cells from hippocampus of E18 
rat brain were cultured as described in Section 2. After being cul- 
tured for 5 days in DMEM containing serum, cells were washed 
with DMEM (-serum) and exposed to 1 mM glutamate for 30 
min. After glutamate was removed from culture medium and 
washed with DMEM (--serum), cells were cultured for 24 h with or 
without peptide (10 nM). Numbers of neurons were counted and 
compared as described in Section 2. Each value is the mean of 8 
samples. *P < 0.01, **P < 0.001 by Student's t-test. 
Gly8 Glul Gin 12 mA 
Glu 4 
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Fig. 6. Helical projection of BINP. Hydrophobic residues are indi- 
cated by circles. Squares and triangles indicate the residues impor- 
tant for the activity in the assays on cholinergic and hippocampal 
neurons, respectively. 
is well known that some linear peptides take on a helical 
conformation when they bind to their receptors on the cell 
surface membrane,  irrespective of their taking on a random 
conformat ion in aqueous solution [13]. Therefore, BINP may 
interact with its receptor on the membrane on the hydropho- 
bic side of its amphiphil ic helix. And differences between the 
two assays may indicate the differences of two kinds of recep- 
tors on two different neurons. Another  explanation for differ- 
ences of the activity may be the susceptibility of each peptide 
to secreted peptidases from each area of the brain in an assay 
medium. We are currently working on identifying the receptor 
for BINP and its parent molecule. 
From the viewpoint of future clinical application, it is no- 
teworthy that the N-terminal Glu residue is not essential for 
neurotrophic activity, because this N-terminal Glu residue 
tends to cyclize to a pyroglutamic residue and the resulting 
peptide has low solubility in aqueous solution. Synthesis and 
biological evaluation of the truncated analogs are now in 
progress in order to search for a smaller peptide having neu- 
rotrophic activity, which will be essential for future drug de- 
sign. 
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